The disclosure relates, in some aspects, to methods and compositions forproduction of immunogenic compositions. Insome embodiments, the disclosure provides host cells which have been treatedex vivo with one or more oligonucleotide agents capableof controlling and/or reducing the differentiation of the host cell. In someembodiments, compositions and methods described by thedisclosure are useful as immunogenic modulators for treating cancer.
